Syros Pharmaceuticals Earnings Estimate

By analyzing Syros Pharmaceuticals' earnings estimates, investors can diagnose different trends across Syros Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Syros Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options. Syros Pharmaceuticals is projected to generate -0.391675 in earnings per share on the 31st of December 2024. Syros Pharmaceuticals earnings estimates module stress-tests analyst consensus about projected Syros Pharmaceuticals EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Syros Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Syros Pharmaceuticals' earnings estimates, investors can diagnose different trends across Syros Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to gain to about (93.3 M) in 2024. Pretax Profit Margin is likely to drop to -17.39 in 2024Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Syros Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Syros Stock please use our How to Invest in Syros Pharmaceuticals guide.